AUPH - Aurinia Pharmaceuticals Inc.
14.81
0.010 0.068%
Share volume: 649,292
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$14.80
0.01
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-02-2024 | 08-01-2024 | 11-07-2024 | 02-27-2025 | 05-12-2025 | 07-31-2025 | 11-04-2025 | 02-26-2026 | |
| Assets | |||||||||
| Total Assets | 516.634 M | 523.529 M | 549.361 M | 550.645 M | 504.850 M | 502.562 M | 527.528 M | 751.587 M | |
| Current Assets | 398.223 M | 409.666 M | 440.459 M | 446.596 M | 405.762 M | 408.970 M | 438.737 M | 491.967 M | |
| Inventories | 39.761 M | 38.853 M | 38.714 M | 39.228 M | 46.195 M | 46.503 M | 44.793 M | 45.690 M | |
| Other Current Assets | 1.995 M | 6.976 M | 2.700 M | 1.129 M | 781.000 K | 665.000 K | 301.000 K | 1.080 M | |
| Short Term Investments | 255.453 M | 297.068 M | 311.605 M | 275.043 M | 246.473 M | 262.131 M | 278.619 M | 317.784 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 64.459 M | 33.407 M | 37.142 M | 83.433 M | 66.428 M | 53.002 M | 73.189 M | 80.213 M | |
| Total Non-current Assets | 199.000 K | 199.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 3.198 M | 3.043 M | 2.887 M | 2.731 M | 2.576 M | 2.421 M | 2.266 M | 2.111 M | |
| Other Assets | 115.213 M | 110.820 M | 106.015 M | 101.318 M | 96.512 M | 91.171 M | 86.525 M | 257.509 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 516.634 M | 523.529 M | 549.361 M | 550.645 M | 504.850 M | 502.562 M | 527.528 M | 751.587 M | |
| Total liabilities | 157.158 M | 158.913 M | 161.359 M | 173.167 M | 154.660 M | 167.261 M | 161.757 M | 170.256 M | |
| Total current liabilities | 71.052 M | 76.903 M | 78.609 M | 97.763 M | 68.406 M | 78.266 M | 76.220 M | 93.724 M | |
| Accounts Payable | 50.270 M | 56.460 M | 56.770 M | 5.187 M | 4.220 M | 3.312 M | 2.214 M | 3.313 M | |
| Other liabilities | 86.106 M | 82.010 M | 82.750 M | 75.404 M | 73.804 M | 76.646 M | 73.288 M | 63.884 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 86.106 M | 82.010 M | 82.750 M | 75.404 M | 73.804 M | 76.646 M | 73.288 M | 63.884 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 359.476 M | 364.616 M | 388.002 M | 377.478 M | 350.190 M | 335.301 M | 365.771 M | 581.331 M | |
| Common stock | 1.313 B | 1.318 B | 1.326 B | 1.315 B | 1.264 B | 1.228 B | 1.227 B | 1.231 B | |
| Retained earnings | -953.071 M | -952.349 M | -937.999 M | -936.570 M | -913.226 M | -891.713 M | -860.162 M | -649.368 M |